Updated September 27 at 6:25am
Biotechnology
75 results total, viewing 1 - 10
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
(Updated 9:57 a.m. and 1:43 p.m.) Nabsys has completed a financial restructuring and is back in business, operating out of its Clifford Street office. more
In one room at the Cambridge Innovation Center in Massachusetts, a large table is shared by a half-dozen people, plugged into laptops and oblivious to passing visitors. In a connecting hallway, overstuffed couches attract workers who would rather … more
Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. more
Rhode Island ranked 33rd in the nation for venture-capital investment in the first quarter, which featured only one deal - $5 million to IlluminOss Medical Inc. more
Four years ago, MedMates was conceived at a brainstorming session about making economic growth happen in Rhode Island. David Goldsmith, co-founder of the group focused on providing a voice and opportunities for businesses in the state's … more
Kelly Nevins is the first full-time executive director of MedMates, Rhode Island’s health care technology network group. She spoke recently with PBN about its short- and long-term goals and her role with the organization. more
The I-195 Redevelopment District Commission moved closer Monday to securing the sale of five acres of land for a biological sciences and mixed-use development. more
Diane Hoffman-Kim is associate professor of medical science and engineering in the Department of Molecular Pharmacology, Physiology, and Biotechnology, and the Center for Biomedical Engineering at Brown University. She was lead author on a recent study showing how miniature brains can be developed in the laboratory for research purposes at surprisingly low cost. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
1 | 2 | 3 | 4 | 5 | 6 | 7 8 | Next »